Skip to content
Optionomics Free · No account needed

Earnings analysis · 10-Q

BGDE earnings analysis

Filed August 14, 2026 · Our reading of the company's report

The latest report

The supplied 10-Q excerpt does not include the financial statements or MD&A needed to assess revenue, margins, EPS, segment performance, balance-sheet trends, or cash flow versus the prior quarter or prior year.…

Read full summary

The supplied 10-Q excerpt does not include the financial statements or MD&A needed to assess revenue, margins, EPS, segment performance, balance-sheet trends, or cash flow versus the prior quarter or prior year. Positive disclosures include effective controls and Nasdaq compliance regained on June 16, 2026, but that compliance is conditional on maintaining at least $5 million of stockholders’ equity each quarter for twelve months. The most material risks are potential Nasdaq delisting, substantial dilution from the Series D financing and warrant, and unresolved obligations with balances of $11.3 million, $14.1 million, and $1.9 million.

Read the original on SEC.gov

What stood out

  • Effective disclosure controls

    Management concluded that disclosure controls and procedures were effective as of June 30, 2026. The filing also states that there were no changes during the three-month period ended June 30, 2026 that materially affected, or were reasonably likely to materially affect, internal control over financial reporting.

  • Nasdaq compliance regained

    The company received Nasdaq confirmation on June 16, 2026 that it had regained compliance with Nasdaq Listing Rules, subject to maintaining stockholders’ equity of at least $5 million in each quarter for a twelve-month period beginning with the quarter ended June 30, 2026.

  • New financing completed

    The company issued 16,700 shares of Series D Convertible Preferred Stock and a five-year warrant for 926,748 common shares on June 30, 2026, providing a new financing source despite associated dilution and covenant constraints.

What to watch

  • Conditional Nasdaq compliance

    Nasdaq compliance remains conditional on maintaining stockholders’ equity of at least $5 million in each quarter for a twelve-month period beginning with the quarter ended June 30, 2026. Failure to comply could result in delisting, reduced capital-markets access, and pressure on the stock price.

  • Variable-price equity dilution

    The Series D Preferred Stock converts at 95% of the lowest daily VWAP over the preceding five trading days, subject to a $1.80 floor, while dividends accrue at 5% annually and can rise to 18% upon triggering events. The related warrant covers 926,748 common shares at an exercise price of $10.81 per share, creating substantial potential dilution.

  • Defaulted and disputed obligations

    Several obligations are described as being in default or otherwise unresolved: the Celsius Promissory Note had an outstanding balance of $11.3 million, the Marshall Loan had an outstanding balance of $14.1 million, and $1.9 million was drawn under the W Capital Loan, which expired in March 2023.

Management's outlook

No quantitative revenue, EPS, margin, or cash-flow guidance was provided in the supplied 10-Q text. The filing states that Nasdaq compliance must be maintained with stockholders’ equity of at least $5 million in each quarter for a twelve-month period beginning with the quarter ended June 30, 2026.

This is our reading of a public filing, not the filing itself. Analysis can contain errors; check the source document for full context.